CN Stock MarketDetailed Quotes
301393 Suzhou Highfine Biotech
- 45.76
- -0.04-0.09%
Trading Dec 5 09:44 CST
4.94BMarket Cap42.45P/E (TTM)
45.86High45.26Low1.02KlotVolume45.72Open45.80Pre Close4.66MTurnover0.29%Turnover Ratio49.96P/E (Static)108.00MShares68.5052wk High2.22P/B1.63BFloat Cap33.1452wk Low54.96Limit Up35.65MShs Float118.43Historical High36.64Limit Down1.31%Amplitude33.14Historical Low0.38Dividend TTM45.73Avg Price434.00lotAsk0.82%Div YieldTTM100Lot Size509.00lotBid
Suzhou Highfine Biotech Key Stats
EPS
According to the latest financial report of Suzhou Highfine Biotech, the latest earnings per share (TTM) for the company is 0.89. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Suzhou Highfine Biotech's latest financial report to see how much their book value per share (BVPS) is currently at 20.76.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Suzhou Highfine Biotech shows that the company's current ratio is 23.41, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Suzhou Highfine Biotech, the quick ratio is 22.19, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Suzhou Highfine Biotech? The latest ROE figure is 4.33%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Suzhou Highfine Biotech, the total asset return on investment (ROA) is 4.17%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Suzhou Highfine Biotech's latest financial report to see how their gross margin is doing - currently at 41.63%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Suzhou Highfine Biotech, the net profit margin is 29.36%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data